πŸ—‚οΈ Navigation

Deep Genomics

AI-powered discovery of genetic medicines.

Visit Website β†’

Overview

Deep Genomics has developed an AI-powered discovery platform, the AI Workbench, that is designed to understand the genetic basis of disease and develop RNA-based therapies. Their platform analyzes vast amounts of data on RNA biology to identify novel targets and design therapeutic candidates with a high probability of success. They are focused on developing treatments for both rare and common genetic diseases.

✨ Key Features

  • AI Workbench platform
  • RNA biology expertise
  • Target identification for genetic diseases
  • Design of RNA therapies (SBOs)
  • BigRNA foundation model

🎯 Key Differentiators

  • AI-first approach to understanding RNA biology.
  • The AI Workbench platform for end-to-end RNA therapy discovery.
  • Focus on steric-blocking oligonucleotides (SBOs).

Unique Value: Uses AI to program and prioritize transformational RNA therapies for a wide range of genetic conditions.

🎯 Use Cases (4)

Discovery of RNA therapies Target identification for genetic diseases Understanding RNA biology Personalized medicine

βœ… Best For

  • Has a pipeline of preclinical programs for various genetic diseases.

πŸ’‘ Check With Vendor

Verify these considerations match your specific requirements:

  • Small molecule or large molecule (protein) drug discovery

πŸ† Alternatives

Envisagenics Ionis Pharmaceuticals Alnylam Pharmaceuticals

Offers a more systematic and predictive approach to RNA therapy development compared to traditional methods.

πŸ’» Platforms

NA

πŸ”Œ Integrations

NA

πŸ›Ÿ Support Options

  • βœ“ Email Support
  • βœ“ Dedicated Support (NA tier)

πŸ’° Pricing

Contact for pricing

Free tier: NA

Visit Deep Genomics Website β†’